![Marga Ortigas-Wedekind](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marga Ortigas-Wedekind
Directeur/Membre du Conseil chez
HEARTBEAM, INC.
Fortune : 160 950 $ au 30/06/2026
Profil
Marga Ortigas-Wedekind is currently an Independent Director at HeartBeam, Inc., a Director at Total Flow Cannula Ltd., and Chief Commercial Officer at Fogarty Innovation LLC since 2019.
Former positions include Marketing Director at Guidant Corp., Director at Itamar Medical Ltd., Director-Market Development at Guidant Vascular Intervention in 2000, EVP-Global Marketing & Product Development at Omnicell, Inc. from 2013 to 2015, SVP-Marketing, Development & Clinical Affairs at Xoft, Inc. in 2008, Executive Vice President-Marketing at iRhythm Holdings, Inc. from 2015 to 2019, and Vice President-Sales & Marketing at Pro-Duct Health, Inc. Education includes undergraduate studies at Wellesley College and an MBA from Stanford Graduate School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HEARTBEAM, INC. 0,39 % | 31/05/2026 | 214 600 ( 0,39 % ) | 160 950 $ | 30/06/2026 |
Postes actifs de Marga Ortigas-Wedekind
| Sociétés | Poste | Début |
|---|---|---|
| HEARTBEAM, INC. | Directeur/Membre du Conseil | - |
Fogarty Innovation LLC | Corporate Officer/Principal | 01/12/2019 |
Total Flow Cannula Ltd.
 Total Flow Cannula Ltd. Medical SpecialtiesHealth Technology Develops novel based medical devices | Directeur/Membre du Conseil | - |
Anciens postes connus de Marga Ortigas-Wedekind
| Sociétés | Poste | Fin |
|---|---|---|
| IRHYTHM HOLDINGS, INC. | Sales & Marketing | 01/07/2019 |
| OMNICELL, INC. | Sales & Marketing | 01/04/2015 |
Xoft, Inc.
 Xoft, Inc. Data Processing ServicesTechnology Services Provides electronic brachytherapy technology services | Directeur Technique/Scientifique/R&D | 01/12/2008 |
Guidant Vascular Intervention | Corporate Officer/Principal | 01/12/2000 |
| ITAMAR MEDICAL LTD. | Directeur/Membre du Conseil | - |
Formation de Marga Ortigas-Wedekind
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Develops cardiovascular medical products | Health Technology |
Omnicell, Inc.
 Omnicell, Inc. Information Technology ServicesTechnology Services Provides automated solutions for hospital medication and supply management | Technology Services |
Xoft, Inc.
Xoft, Inc. Data Processing ServicesTechnology Services Provides electronic brachytherapy technology services | Technology Services |
iRhythm Technologies, Inc.
 iRhythm Technologies, Inc. Medical SpecialtiesHealth Technology Provides monitoring and diagnostic solutions for detection of cardiac arrhythmias | Health Technology |
Pro-Duct Health, Inc.
 Pro-Duct Health, Inc. Medical SpecialtiesHealth Technology Develops medical products for the evaluation of breast cancer | Health Technology |
Wellesley College
 Wellesley College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Itamar Medical Ltd.
 Itamar Medical Ltd. Medical SpecialtiesHealth Technology Manufactures sleep testing disease devices | Health Technology |
Guidant Vascular Intervention | |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HeartBeam, Inc.
 HeartBeam, Inc. Medical SpecialtiesHealth Technology Provides portable, easy to use and medical-grade heart attack detection devices | Health Technology |
Fogarty Innovation LLC | |
Total Flow Cannula Ltd.
Total Flow Cannula Ltd. Medical SpecialtiesHealth Technology Develops novel based medical devices | Health Technology |
Choisissez Zonebourse 
